e-Edition
Obituaries
In Loving Memory
Magazines
Subscribe
Login to Comment
Register
jobs
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Life
Commentary
Contact
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
(OP:
NUMIF
)
0.0205
UNCHANGED
Streaming Delayed Price
Updated: 2:37 PM EST, Nov 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about NUMIF
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Psychedelic Stock Gainers And Losers From April 12, 2023
April 12, 2023
Via
Benzinga
Check Out The Canadian Company Building On Several Vertical Psychedelics Businesses
April 12, 2023
Mental healthcare company Numinus Wellness Inc. (OTCQX: NUMIF)’s new clinic licensing model, The Numinus Network offers independent practitioners the chance to own and operate their own clinic under...
Via
Benzinga
Psychedelic Stock Gainers And Losers From April 11, 2023
April 11, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From April 10, 2023
April 10, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From April 7, 2023
April 07, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From April 6, 2023
April 06, 2023
Via
Benzinga
This Psychiatrist Calls Cannabis Is A Minor-League Psychedelic & Undervalued Investment Opportunity
April 06, 2023
Cannabis is a psychedelic that belongs to the group of mind-manifesting substances, according to Dr. Julie Holland. "When you get high on cannabis, you can see your thoughts differently, and it can...
Via
Benzinga
Psyched: Canada's Case For Psilocybin Access And Microdose Trial, US Reform Update, Battle With DEA & More
April 05, 2023
Canadian Patients Demand Access To Psilocybin: Federal Lawsuit, Official Petition & Failing Mechanism A patient-led lawsuit against the Canadian government is claiming access to therapeutic psilocybin...
Via
Benzinga
Seelos Therapeutics, ATAI Life Sciences Among Top Psychedelic Movers Of Today
April 03, 2023
Via
Benzinga
Want To Become A Psychedelic-Assisted Therapist? This Company Offers A 'Pathway' Course
March 27, 2023
Mental healthcare company Numinus Wellness Inc. (OTCQX: NUMIF) is launching a collection of psychedelic-assisted therapist (PAT) training courses for practitioners with multi-modal teaching methods.
Via
Benzinga
In-Clinic Ketamine Businesses Are Shutting Down All Across The US, A Rising Trend?
March 15, 2023
Closely following the announcement of what's to become of the new regulations for telehealth, including ketamine therapy, several of in-clinic treatment centers have announced they are closing their...
Via
Benzinga
EXCLUSIVE: Bienstar Wellness Expands Ibogaine Treatment For Addiction To Curitiba, 3rd Brazilian City Covered By The Co.
March 13, 2023
Bienstar Wellness, through its Brazilian clinics, Clínicas Beneva, will begin offering ibogaine treatments for addiction in Curitiba, the capital of the Paraná province in Brazil, starting in March.
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 9, 2023
March 09, 2023
Via
Benzinga
Numinus Wellness, Seelos Therapeutics Among Top Psychedelic Movers Of Today
March 08, 2023
Via
Benzinga
Will Canada Follow Australia And Approve Psychedelic Assisted Therapy? This CEO Believes It Will
March 08, 2023
On this special yearend Trade To Black Podcast, TDR Founder Shadd Dales spoke with Payton Nyquvest, CEO of Numinus Wellness Inc. (OTC: NUMIF) regarding recent company events and those within the...
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 6, 2023
March 06, 2023
Via
Benzinga
Cybin, GH Research Among Top Psychedelic Movers Of Today
March 03, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 2, 2023
March 02, 2023
Via
Benzinga
Cybin, GH Research Among Top Psychedelic Movers Of Today
March 01, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 28, 2023
February 28, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 27, 2023
February 27, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 24, 2023
February 24, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 23, 2023
February 23, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 22, 2023
February 22, 2023
Via
Benzinga
Psyched: Four New States With Reform Bills, Psilocybin For Genetic Disorders And Functional Neurological Disorder, Struggle For Access & More
February 21, 2023
Psychedelics States Reform: Utah, Iowa, Missouri and Oklahoma’s New Bills; Hawaii, Arizona and Washington's Green Lights, New Hampshire's Setback Earlier this week, three bills were introduced and...
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 21, 2023
February 21, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 20, 2023
February 20, 2023
Via
Benzinga
ATAI Life Sciences, GH Research Among Top Psychedelic Movers Of Today
February 17, 2023
Via
Benzinga
Numinus Debuts 3rd Research Site In US, Touts Faster Services & More Participants
February 17, 2023
Numinus Wellness (OTCQX: NUMIF) expanded its clinical research capabilities into Phoenix, where the psychedelic-assisted therapy provider currently operates mental health clinics.
Via
Benzinga
Numinus Expands Research Capabilities with new Phoenix Clinical Research Site
February 17, 2023
The Phoenix Site is Numinus’ Third Research Facility in the US VANCOUVER, BC, Feb. 17, 2023 – Numinus Wellness Inc. (“Numinus”) (TSX:NUMI) (OTCQX:NUMIF), a mental health care company advancing...
Via
PressReach
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
wpDiscuz
Insert
